EP Patent

EP0461546A2 — Antiherpes peptide derivatives having a 1,4-dioxo-C4 N-terminus

Assigned to Bio Mega Boehringer Ingelheim Research Inc · Expires 1991-12-18 · 34y expired

What this patent protects

Disclosed herein are peptide derivatives of the formula R¹NH-CO-Q-C(O)-NR²-CH[CH₂C(O)-Y]-C(O)-NH-CH[CR³(R⁴)-COOH]-C(W)-NH-CHR⁵-Z wherein R¹ is an optionally substituted alkyl or optionally substituted phenylalkyl, R² is hydrogen or alkyl, R³ and R⁴ each independently is hydrogen …

USPTO Abstract

Disclosed herein are peptide derivatives of the formula R¹NH-CO-Q-C(O)-NR²-CH[CH₂C(O)-Y]-C(O)-NH-CH[CR³(R⁴)-COOH]-C(W)-NH-CHR⁵-Z wherein R¹ is an optionally substituted alkyl or optionally substituted phenylalkyl, R² is hydrogen or alkyl, R³ and R⁴ each independently is hydrogen or alkyl, or R³ and R⁴ are joined to form a cycloalkyl, R⁵ is alkyl, cycloalkyl or (cycloalkyl)alkyl, Q is a divalent radical, for example, -CH₂CH₂-, -CH=CH- or 1,2-cyclohexanediyl, which serves as a two carbon spacer, W is oxo or thioxo, Y is, for example, an alkoxy or a monosubstituted or disubstituted amino, and Z is a terminal unit, for example, hydrogen, COOH or CH₂OH. The derivatives are useful for treating herpes infections.

Drugs covered by this patent

Patent Metadata

Patent number
EP0461546A2
Jurisdiction
EP
Classification
Expires
1991-12-18
Drug substance claim
No
Drug product claim
No
Assignee
Bio Mega Boehringer Ingelheim Research Inc
Source
FDA Orange Book + USPTO grounding via Google Patents

Bibliographic data sourced from FDA Orange Book + USPTO public records. Plain-English summary generated by AI grounded in source text. Patent term extensions (PTR, SPC, pediatric) may shift the effective expiry. Not legal advice.

Track this patent

Get a daily-checked alert when vulnerability score, expiry, classification, or assignee changes. Email, Slack, or Teams delivery. Pro: 50 watches, Free: 3.